Locked price vs escalating price
He & She MD vs Maximus: Which Price Survives Titration? (2026)
He & She MD or Maximus? Side-by-side 2026 pricing, medication and service comparison, extended to six and twelve-month totals.
Published · Pricing as published in our provider dataset, synced · Editorial scores 7.0 and 7.0 out of 10
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
If He & She MD and Maximus are the two tabs still open, the deciding information is not on either homepage — it is in what happens after the first month.
The headline both platforms advertise is a month-one number. Maximus keeps that number; He & She MD moves from $139 to $191, which is what actually determines the twelve-month bill.
Below, the two programs are set against the things that change the bill — the advertised rate, the rate after the promotion expires, the medication class and the inclusions. No number here is inferred; if a provider does not publish it, the table says so.
The short answer
- Lowest 12-month cost
- Maximus — $1,596 against $1,980 at He & She MD, on each provider's own best published pricing.
- Most predictable bill
- Maximus — Flat rate at every dose, so titration does not change what you are charged.
- Tirzepatide access
- He & She MD — Tirzepatide at $199/mo; the other side publishes semaglutide only.
- Easiest to pay for
- He & She MD — Neither publishes financing; both expect the full amount monthly.
He & She MD vs Maximus: the specification
This is the whole comparison in one screen. The sections underneath explain which of these rows should decide it.
| He & She MD | Maximus | |
|---|---|---|
| Advertised price | Semaglutide from $139/mo, oral semaglutide and tirzepatide from $199/mo | $132.99/mo |
| Rate after promotions | $191/mo | $133/mo |
| Pricing structure | Introductory term, then renewal at a higher rate | Flat rate at every dose |
| Medication | Compounded semaglutide injection, oral semaglutide and compounded tirzepatide injection | Compounded semaglutide |
| Price transparency | Published upfront | Published upfront |
| Tirzepatide | $199/mo | Not published |
| Support model | Coaching built into the plan | No coaching program stated |
| Shipping | Free expedited shipping with no upcharges | Home delivery |
| Patient reviews | 4,180 | 2,896 |
| eRxDoctor score | 7.0/10 | 7.0/10 |
What you will have spent by month twelve
The cheapest first month and the cheapest year are frequently different providers. Here is what each one costs across a realistic course of treatment, on published pricing.
| He & She MD | Maximus | |
|---|---|---|
| First month | $139 | $133 |
| Months 2 onward | $191/mo | $133/mo |
| 6-month total | $834 | $798 |
| 12-month total | $1,980 | $1,596 |
| Best published plan | No multi-month discount published | No multi-month discount published |
The twelve-month spread is $384. That is the number to hold He & She MD against: it has to justify roughly $32 extra every month.
Price escalation to plan for: He & She MD moves from $139 to $191, a 37% increase. Set a calendar reminder for the month it changes.
What happens to the price as your dose goes up
Semaglutide and tirzepatide are titrated upward over the first months of treatment. Some providers price per milligram in all but name, so the invoice climbs alongside the dose; others hold one rate the whole way.
Maximus is in the second group: a low flat rate with a simple direct-pay structure and nothing bolted on. He & She MD is in the first — the headline rates are six-month terms that renew 30-45% higher — which means the number you compared at signup is not the number you will be paying at month four.
The fix is one question at intake: what do I pay at maintenance dose? Everything else about pricing follows from that answer.
A closer look at He & She MD
The pitch is three medication formats and a coaching app included, under a named board-certified obesity-medicine CMO. He & She MD bundles compounded GLP-1 medication with a coaching app that carries 1:1 clinician messaging, GLP-1-specific guidance and progress tracking. Semaglutide injections start at $139/month, oral semaglutide and tirzepatide at $199/month, each a six-month introductory rate. Free expedited shipping, no membership fee, no insurance required.
You start with 2-3 minute intake with no payment required to check eligibility; medication arrives via free expedited shipping with no upcharges. The price behaves as introductory term, then renewal at a higher rate.
Ongoing care is coaching app with 1:1 clinician messaging and progress tracking, no extra charge, and the medication list runs to compounded semaglutide injection, oral semaglutide and compounded tirzepatide injection.
He & She MD pros
- Coaching app, 1:1 clinician messaging and progress tracking included at no extra cost
- Three formats: semaglutide injection, oral semaglutide, tirzepatide injection
- $139/mo intro price is competitive for a program with this much bundled support
- Named, dual board-certified obesity-medicine Chief Medical Officer
He & She MD cons
- Pricing is structured as six-month terms, not true month-to-month
- Headline prices are 6-month intro rates that renew 30-45% higher
- The 15-25 lbs in 12 weeks figure is self-reported retrospective data, not trial data
The reservation worth holding, particularly next to Maximus: the headline rates are six-month terms that renew 30-45% higher.
Inside the Maximus program
$132.99 per Month
The process is telemedicine intake, no clinic visits, then home delivery. On money, expect flat rate at every dose — published upfront.
Support: prescriptions approved by licensed doctors, filled through U.S. pharmacies. The medications on offer are compounded semaglutide.
Maximus pros
- Simple, straightforward direct-pay model
- Convenient telemedicine access with no clinic visits
- Low flat rate at $132.99/month
- Medication filled through trusted U.S. pharmacies
Maximus cons
- Smallest patient base on this list, limited public reviews and track record
- Compounded medication only, no branded Ozempic, Wegovy, or Zepbound
- Limited published detail on tirzepatide availability and program features
Read next to He & She MD, the weak point: the smallest patient base here, with limited published detail on tirzepatide.
Which one fits which patient
Choose He & She MD if:
- the level of clinical contact suits you: coaching app with 1:1 clinician messaging and progress tracking, no extra charge
- the feature you would actually use: three medication formats and a coaching app included, under a named board-certified obesity-medicine CMO
- you want coaching app with 1:1 clinician messaging and progress tracking, no extra charge rather than a prescription alone
- you want tirzepatide available without changing provider later
Choose Maximus if:
- the level of clinical contact suits you: prescriptions approved by licensed doctors, filled through U.S. pharmacies
- you want to start on their timeline: telemedicine intake, no clinic visits
- delivery works the way you want it to: home delivery
- the monthly rate is the constraint — $133/mo against $191/mo
The trade-offs, stated plainly
On price. Maximus is the cheaper program at $133/mo against $191/mo. What Maximus gives up for that is the smallest patient base here, with limited published detail on tirzepatide; what He & She MD charges for is three medication formats and a coaching app included, under a named board-certified obesity-medicine CMO.
On clinical contact. Coaching app with 1:1 clinician messaging and progress tracking, no extra charge at He & She MD; prescriptions approved by licensed doctors, filled through U.S. pharmacies at Maximus. Neither is a substitute for in-person care if you have complicating conditions, and both bill you directly rather than your insurer.
On medication. He & She MD covers compounded semaglutide injection, oral semaglutide and compounded tirzepatide injection; Maximus covers compounded semaglutide. Only He & She MD publishes a tirzepatide route, which matters if semaglutide underdelivers.
On access. He & She MD advertises 2-3 minute intake with no payment required to check eligibility and free expedited shipping with no upcharges; Maximus advertises telemedicine intake, no clinic visits and home delivery. Neither publishes its state coverage, so confirm you are eligible before paying for anything.
What the evidence actually says
Neither He & She MD nor Maximus manufactures the molecule it prescribes, and the clinical evidence behind GLP-1 treatment belongs to the drug rather than to any platform selling access to it.
Cardiovascular benefit has been demonstrated for semaglutide in a specific population: adults with overweight or obesity and existing cardiovascular disease but no diabetes, per NEJM, SELECT.
In SURMOUNT-4, stopping tirzepatide after a lead-in period produced significant weight regain, where staying on it did not, per JAMA, SURMOUNT-4.
Take the clinical questions to the prescribing clinician at whichever platform you choose; take the pricing questions to their support team before you pay.
He & She MD vs Maximus: common questions
Do He & She MD or Maximus take insurance?
Both run on a direct-pay basis: you pay the platform and it does not bill your insurer. Neither publishes HSA/FSA acceptance, so budget the full amount as out-of-pocket spending.
How fast can I start with He & She MD compared with Maximus?
He & She MD advertises 2-3 minute intake with no payment required to check eligibility, with free expedited shipping with no upcharges. Maximus advertises telemedicine intake, no clinic visits, with home delivery. Both are subject to clinician review and to whether your state and health history clear, so treat the advertised timeline as a best case rather than a commitment.
Is coaching included with He & She MD or Maximus?
He & She MD includes coaching app with 1:1 clinician messaging and progress tracking, no extra charge in the monthly price. Maximus provides prescriptions approved by licensed doctors, filled through U.S. pharmacies, without a separate coaching program. If medication alone has failed you before, the bundled version is the one to price properly rather than the one to cut.
Which has more patient reviews, He & She MD or Maximus?
He & She MD, with 4,180 against 2,896. Ratings across this market cluster tightly, so volume is the more useful signal: it indicates how much operational load the platform has already absorbed, not how good the medication is.
Do He & She MD and Maximus prescribe the same medication?
Both dispense compounded GLP-1 preparations. He & She MD lists compounded semaglutide injection, oral semaglutide and compounded tirzepatide injection and Maximus lists compounded semaglutide, so the molecules overlap even where the formulary does not match exactly.
Does He & She MD or Maximus offer tirzepatide?
He & She MD does, at $199/mo. Maximus publishes compounded semaglutide only, so moving to tirzepatide would mean moving provider — a new intake, a new price, and the loss of any rate you had locked in.
The verdict
Strictly on cost, Maximus takes it — $1,596 to $1,980 over twelve months.
Where He & She MD justifies itself is three medication formats and a coaching app included, under a named board-certified obesity-medicine CMO. Where it does not is anywhere the extra spend buys features you will never open.
Neither choice is irreversible. Start with the program whose weaknesses you can tolerate, and reassess at month three when you know how you respond to the medication.
Keep comparing
- Directmeds vs He & She MDPublished price vs quote-only
- Enhance MD vs He & She MDBudget vs premium
- Novi vs MaximusLarge platform vs smaller platform
- Mochi Health vs MaximusLocked price vs escalating price
- IVIM Health vs LIV BodyLocked price vs escalating price
- TMates vs He & She MDLocked price vs escalating price
See every provider in context on the weight loss rankings, or browse the full comparison index.
Disclaimers and methodology
Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.
Some links are affiliate links and may generate commission at no extra cost to you.
Pricing reflects what each provider published as of the sync date above and changes frequently; confirm the current rate, and the rate at your maintenance dose, before you pay. Six- and twelve-month totals are calculated from those published rates and exclude anything a provider bills separately.
eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by He & She MD or Maximus, and does not sell treatment. Read our ranking methodology.